M. Motta

Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop.

D. Dondi, Patrízia Limonta, Roberta M. Moretti et al. · PubMed · 1994 · 150 citations

Urology, Lhrh Antagonist, Lhrh System +13

Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP.

Patrízia Limonta, D. Dondi, Roberta M. Moretti et al. · The Journal of Clinical Endocrinology & Metabolism · 1992 · 146 citations

Urology, Hormone-releasing Hormone Agonists, Endocrine-related Cancer +13

Sexual differentiation of the brain: role of testosterone and its active metabolites.

P. Negri‐Cesi, Alessandra Colciago, F. Celotti et al. · PubMed · 2004 · 92 citations

Adrenal Progesterone: Factors Controlling Its Secretion1

Francesco Piva, Patricia Gagliano, M. Motta et al. · Endocrinology · 1973 · 91 citations

Fertility, Plasma Progesterone, Comparative Endocrinology +21

Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145.

Roberta M. Moretti, Marina Montagnani Marelli, D. Dondi et al. · The Journal of Clinical Endocrinology & Metabolism · 1996 · 90 citations · Full text

Mitogenic Action, Du 145, Urology +14